通过远程医疗网络为糖尿病成人提供低强度心理健康支持(LISTEN):混合1型有效性实施试验方案
该方案拟开展混合1型有效性-实施试验,含双臂平行随机对照试验与混合方法过程评价。计划招募454名经历糖尿病痛苦的澳大利亚糖尿病成人,按1:1随机接受LISTEN低强度心理健康支持项目或常规照护,主要终点为6个月时糖尿病痛苦的组间差异,并评估成本效果与实施结局。
要点
- LISTEN为基于问题解决治疗框架、经远程医疗实施的简短低强度心理健康支持项目。
- 计划纳入454名经历糖尿病痛苦的澳大利亚糖尿病成人,按1:1随机分组。
- 主要终点为6个月时糖尿病痛苦的组间差异,并开展成本效果与RE-AIM实施评价。
核心结论
- 预期LISTEN可减少糖尿病成人的糖尿病痛苦,其实用性试验结果将确定LISTEN是否有效、具成本效果并应大规模实施。
研究设计与样本
- 混合1型有效性-实施试验,包含双臂平行随机对照试验与混合方法过程评价。
- 计划招募454名澳大利亚糖尿病成人,主要通过网络全国糖尿病服务计划招募,入组条件为经历糖尿病痛苦升高。
- 参与者按1:1比例随机分配至LISTEN干预组或常规照护组。
主要发现
- 主要结局为6个月(T2)随访时糖尿病痛苦的组间差异。
- 次要结局包括干预对心理痛苦、一般情绪健康和应对自我效能的即刻(8周,T1)与较长期(6个月,T2)效应。
- 将开展试验内经济学评价,并按RE-AIM框架用混合方法评估实施结局,数据收集包括定性访谈和现场记录。
关键数值与推荐
- LISTEN为基于问题解决治疗框架的简短低强度心理健康支持项目,通过远程医疗实施。
- 常规照护为基于网络的糖尿病与情绪健康资源。
- 数据通过在线评估在基线(T0)、8周(T1)和6个月(T2,主要终点)随访时收集。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mental health problems are common among people with diabetes. However, evidence-based strategies for the prevention and early intervention of emotional problems in people with diabetes are lacking. Our aim is to assess the real-world effectiveness, cost-effectiveness, and implementation of a Low-Intensity mental health Support via a Telehealth Enabled Network (LISTEN), facilitated by diabetes health professionals (HPs). METHODS: A hybrid type I effectiveness-implementation trial, including a two-arm parallel randomised controlled trial, alongside mixed methods process evaluation. Recruited primarily via the National Diabetes Services Scheme, Australian adults with diabetes (N = 454) will be eligible if they are experiencing elevated diabetes distress. Participants are randomised (1:1 ratio) to LISTEN-a brief, low-intensity mental health support program based on a problem-solving therapy framework and delivered via telehealth (intervention) or usual care (web-based resources about diabetes and emotional health). Data are collected via online assessments at baseline (T0), 8 weeks (T1) and 6 months (T2, primary endpoint) follow-up. The primary outcome is between-group differences in diabetes distress at T2. Secondary outcomes include the immediate (T1) and longer-term (T2) effect of the intervention on psychological distress, general emotional well-being, and coping self-efficacy. A within-trial economic evaluation will be conducted. Implementation outcomes will be assessed using mixed methods, according to the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Data collection will include qualitative interviews and field notes. DISCUSSION: It is anticipated that LISTEN will reduce diabetes distress among adults with diabetes. The pragmatic trial results will determine whether LISTEN is effective, cost-effective, and should be implemented at scale. Qualitative findings will be used to refine the intervention and implementation strategies as required. TRIAL REGISTRATION: This trial has been registered with the Australian New Zealand Clinical Trials Registry (ACTRN: ACTRN12622000168752) on 1 February, 2022.
引用
- Holloway EE, Gray S, Mihalopoulos C, et al. Low-Intensity mental health Support via a Telehealth Enabled Network for adults with diabetes (LISTEN): protocol for a hybrid type 1 effectiveness implementation trial. Trials. 2023. PMID: 37221629. doi:10.1186/s13063-023-07338-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。